FDA Adverse Event Injury Summary report: N

HYDRUS MICROSTENT

MDR report key: 11878861 · Received May 25, 2021

Report

Report Number
3016075957-2021-00019
Event Type
Injury
Date Received
May 25, 2021
Report Date
May 25, 2021
Manufacturer
IVANTIS, INC.
Product Code
OGO
UDI-DI
00867487000134
PMA / PMN Number
P170034
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE HYDRUS MICROSTENTS REMAIN IMPLANTED IN THE PATIENTS AND ARE NOT AVAILABLE FOR EVALUATION. DEVICE IDENTIFIERS AND ADDITIONAL PATIENT INFORMATION HAVE BEEN REQUESTED; A SUPPLEMENTAL REPORT WILL BE FILED IF NEW INFORMATION IS RECEIVED. ELEVATED IOP, MICROSTENT-IRIS TOUCH, AND MICROSTENT OBSTRUCTION ARE LISTED IN THE DEVICE LABELING AS POTENTIAL ADVERSE EVENTS. MANUFACTURER REFERENCE #: (B)(4).

Description of Event or Problem · 1

ON (B)(6) 2021 THE SURGEON REPORTED THAT HE HAD "A FEW" PATIENTS WHO HAD POSTOPERATIVE INTRAOCULAR PRESSURE (IOP) ELEVATION AND IRIS TISSUE ON THE INLET OF THE HYDRUS MICROSTENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
777321 HYDRUS MICROSTENT INTRAOCULAR PRESSURE LOWERING IMPLANT OGO IVANTIS, INC. F00022 00867487000134

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention